RxDoctor Payments Data

Lloyd Hughes, DO

Family Medicine · St Francis, WINPI 1710065297

Payments from drug & device makers

$332in general payments, 2019–2025

Across 14 payments — averaging $23.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$97
  • AbbVie$76
  • Exact Sciences$32
  • GSK$29
  • Edwards Lifesciences$27
  • Bayer$25
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$332100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$332 in reported general payments places this provider in the 75th percentile of 1,482 family medicine providers in Wisconsin.

See all family medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$147,968
Medicare patients
426
Services billed
1,547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban57$68,419
OzempicSemaglutide42$52,883
JanuviaSitagliptin Phosphate18$27,246
TrulicityDulaglutide16$27,000
FarxigaDapagliflozin Propanediol17$26,507
MounjaroTirzepatide23$23,911
XareltoRivaroxaban13$19,533
JardianceEmpagliflozin13$18,322
MyrbetriqMirabegron18$17,654
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$13,088
Soliqua 100-33Insulin Glargine/Lixisenatide13$9,493
Breo ElliptaFluticasone/Vilanterol11$8,223
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$3,214
Atorvastatin Calcium302$3,145
Testosterone21$3,028

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$97$52,88342 claims
Lilly USA, LLCTrulicity, Mounjaro$17$50,91239 claims
AstraZenecaFarxiga$15$26,50717 claims
GSKTrelegy Ellipta, Breo Ellipta$29$21,31223 claims
AbbVieSynthroid$76$61313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,482 family medicine providers in Wisconsin.

Other family medicine in St Francis

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →